Results

業績

英文論文

原著論文

  • Influence of dosing pattern of antipsychotics on treatment outcome of delirium in
    patients with advanced cancer.
    Abe A, Fujisawa D, Miyajima K, Takeuchi E, Takeuchi M, Mimura M, Imai K, Uemura K, Watanabe H, Matsuo N, Matsuda
    Y, Maeda I, Ogawa A, Yoshiuchi K, Iwase S.
    Jpn J Clin Oncol. 2023; 53: 321-326.
  • Transcriptome profiling of immune cell types in peripheral blood reveals common and specific pathways involved in the pathogenesis of myositis-specific antibody-positive inflammatory myopathies
    Yusuke Sugimori, Yukiko Iwasaki, Yusuke Takeshima, Mai Okubo, Satomi Kobayashi, Hiroaki Hatano, Saeko Yamada, Masahiro Nakano, Ryochi Yoshida1, MD, PhD, Mineto Ota, Yumi Tsuchida, Yasuo Nagafuchi, Kenichi Shimane , Ken Yoshida, Daitaro Kurosaka, Shuji Sumitomo, Hirofumi Shoda, Kazuhiko Yamamoto, Tomohisa Okamura, Keishi Fujio ACR open Rheumatology 2023; 5: 93-102.
  • Combined plasma metabolomic and transcriptomic analysis identify histidine as a biomarker and potential contributor in SLE pathogenesis
    Yukiko Iwasaki, Yusuke Takeshima, Masahiro Nakano, Mai Okubo, Mineto Ota, Akari Suzuki, Yuta Kochi, Tomohisa Okamura, Takaho Endo, Ichiro Miki, Kazuhiro Sakurada, Kazuhiko Yamamoto, Keishi Fujio　　　　　　　　　　　　　　　　　　　　　Rheumatology. 2023; 62: 905-913.
  • Phase III, international, multicentre, double-blind, dose increment, parallel-arm,
    randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol
    Hiromichi Matsuoka, Katherine Clark, Belinda Fazekas, Shunsuke Oyamada, Linda Brown, Hiroto Ishiki, Yoshinobu Matsuda, Hideaki Hasuo, Keisuke Ariyoshi, Jessica Lee, Brian Le, Peter Allcroft, Slavica Kochovska, Melanie Lovell, Meera Agar, Eriko Satomi, Satoru Iwase, Jane Phillips, Atsuko Koyama, and David C Currow
    BMJ Open. 2022; 12: e050182
  • Evidence-Based Practice Guideline for the Management of Lymphedema Proposedby the Japanese Lymphedema Society
    Kaoru Kitamura, Satoru Iwase, Yoshifumi Komoike, Yoshinari Ogawa , Kuniko Utsugi , Daigo Yamamoto , Hiroki Odagiri
    Lymphat Res Biol. 2022; 20: 539-547.
  • Association of Antipsychotic Dose With Survival of Advanced Cancer Patients With Delirium.
    Yokomichi N, Maeda I, Morita T, Yoshiuchi K, Ogawa A, Hisanaga T, Sakashita A, Nakahara R, Kaneishi K, Iwase S.
    J Pain Symptom Manage. 2022; 64: 28-36.
  • A decision tree prediction model for a short-term outcome of delirium in patients
    with advanced cancer receiving pharmacological interventions: A secondary analysis of a multicenter and prospective observational study (Phase-R).
    Kurisu K, Inada S, Maeda I, Ogawa A, Iwase S, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Nakahara R, Kaneishi K, Nakajima N, Sumitani M, Yoshiuchi K; Phase-R Delirium Study Group.
    Palliat Support Care. 2022; 20: 153-158.
  • Immune cell multi-omics analysis reveals contribution of oxidative phosphorylation to B cell functions and organ damage of lupus
    Yusuke Takeshima, Yukiko Iwasaki, Masahiro Nakano, Yuta Narushima, Mineto Ota, Yasuo Nagafuchi, Shuji Sumitomo, Tomohisa Okamura, Keith B Elkon, Kazuyoshi Ishigaki, Akari Suzuki, Yuta Kochi, Kazuhiko Yamamoto, Keishi Fujio　　　　　Annals of the Rheumatic Diseases. 2022; 8: 845-853.
  • Morphine for dyspnoea in chronic obstructive pulmonary disease: a before-after
    efficacy study.
    Matsuda Y, Morita T, Matsumoto H, Hosoi K, Kusama K, Kohashi Y, Morishita H, Kaku S, Ariyoshi K, Oyamada S, Inoue Y,
    Iwase S, Yamaguchi T, Nishikawa M.
    BMJ Support Palliat Care. 2021; 12: 427-432
  • Low-Dose Trazodone for Delirium in Patients with
    Cancer Who Received Specialist Palliative Care: A Multicenter Prospective Study.
    Maeda I, Inoue S, Uemura K, Tanimukai H, Hatano Y, Yokomichi N, Amano K, Tagami K, Yoshiuchi K, Ogawa A, Iwase S.
    J Palliat Med. 2021; 24: 914-918.
  • Prevalence of Extrapyramidal Symptoms in Cancer Patients Referred to Palliative
    Care: A Multicenter Observational Study (JORTC PAL12).
    Ishiki H, Hamano J, Nagaoka H, Matsuda Y, Tokoro A, Matsuoka H, Izumi H, Sakashita A, Kizawa Y, Oyamada S, Yamaguchi T Iwase S.
    Am J Hosp Palliat Care. 2021; 38: 823-829.
  • Study protocol for a randomised, placebo- controlled, single-blind phase II study ofthe efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)
    Matsuda Y, Morita T, Oyamada S, Ariyoshi K, Yamaguchi T, Iwase S.
    BMJ Open. 2021; 11: e043156
  • Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07.
    Matsuda Y, Morita T, Matsumoto H, Hosoi K, Kusama K, Kohashi Y, Morishita H, Kaku S, Ariyoshi K, Oyamada S, Inoue Y, Iwase S, Yamaguchi T, Nishikawa M.
    Palliat Med.Rep. 2021; 2: 15-20.
  • Evaluation of quality indicators near death in older adult cancer decedents in
    Japan: A nationwide retrospective cohort study.
    Shirane S, Michihata N, Yoshiuchi K, Ariyoshi K, Iwase S, Morita K, Matsui H, Fushimi K, Yasunaga H.
    Jpn J Clin Oncol. 2021; 51: 1643-1648.
  • Reversibility of delirium in Ill-hospitalized cancer patients: Does underlying etiology
    matter?
    Matsuda Y, Maeda I, Morita T, Yamauchi T, Sakashita A, Watanabe H, Kaneishi K, Amano K, Iwase S, Ogawa A, Yoshiuchi K; Phase-R Delirium Study Group.
    Cancer Med. 2020; 9: 19-26.
  • Development of Japanese Versions of the Control Preferences Scale and
    Information Needs Questionnaire: Role of Decision-Making and Information Needs for Japanese Breast Cancer Patients.
    Azuma K, Kawaguchi T, Yamaguchi T, Motegi S, Yamada K, Onda K, Iwase S, Unezaki S, Takeuchi H.
    Patient Prefer Adherence. 2021; 15: 1017-1026.
  • Olanzapine versus Metoclopramide for Treatment of Nausea and Vomiting in
    Advanced Cancer Patients with Incomplete Malignant Bowel Obstruction.
    Kaneishi K, Imai K, Nishimura K, Sakurai N, Kohara H, Ishiki H, Kanai Y, Oyamada S, Yamaguchi T, Morita T, Iwase S.
    J Palliat Med. 2020; 23: 880-881.
  • Safety and effectiveness of antipsychotic medication for delirium in patients with
    advanced cancer: A large-scale multicenter prospective observational study in real-world palliative care settings.
    Maeda I, Ogawa A, Yoshiuchi K, Akechi T, Morita T, Oyamada S, Yamaguchi T, Imai K, Sakashita A, Matsumoto Y, Uemura K, Nakahara R, Iwase S; Phase-R Delirium Study Group.
    Gen Hosp Psychiatry. 2020; 67: 35-41.
  • Predictors of duloxetine response in patients with neuropathic cancer pain:
    a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
    Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A,
    Matsuda Y, Tahara K, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Nakura M, Morita T, Yamaguchi T, Koyama
    A.Support Care Cancer. 2020; 28: 2931-2939.
  • Efficacy of oral administration of cystine and theanine in colorectal cancer
    patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03).
    Hamaguchi R, Tsuchiya T, Miyata G, Sato T, Takahashi K, Miura K, Oshio H, Ohori H, Ariyoshi K, Oyamada S, Iwase S.
    Support Care Cancer. 2020; 28: 3649-3657.
  • The efficacy of specialised rehabilitation using the Op-reha Guide for cancer
    patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02).
    Nishiyama N, Matsuda Y, Fujiwara N, Ariyoshi K, Oyamada S, Narita K, Ishii R, Iwase S.
    BMC Palliat Care. 2020; 19: 164.
  • How successful are we in relieving terminal dyspnea in cancer patients?
    A real-world multicenter prospective observational study.
    Mori M, Morita T, Matsuda Y, Yamada H, Kaneishi K, Matsumoto Y, Matsuo N, Odagiri T, Aruga E, Watanabe H, Tatara R,
    Sakurai H, Kimura A, Katayama H, Suga A, Nishi T, Shirado AN, Watanabe T, Kuchiba A, Yamaguchi T, Iwase S.
    Support Care Cancer. 2020; 28: 3051-3060.
  • A survey of practice in management of malignancy-related ascites in Japan.
    Kanai Y, Ishiki H, Maeda I, Iwase S.
    PLoS One. 2019;14: e0220869
  • Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or
    Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
    Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A,
    Shinomiya T, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Matsuda Y, Morita T, Koyama A, Yamaguchi T.
    J Pain Symptom Manage. 2019; 58: 645-653.
  • Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in
    Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).
    Okuyama T, Yoshiuchi K, Ogawa A, Iwase S, Yokomichi N, Sakashita A, Tagami K, Uemura K, Nakahara R, Akechi T;
    Phase‐R Delirium Study Group.
    Oncologist. 2019; 24: e574-e582.

和文論文

著書

  • 増大特集　症例から学ぶ　疾患と検査値の推移　“全身性エリテマトーデス”
    岩崎　由希子
    検査と技術　（医学書院）　第51巻　第5章 (2023)
  • がんでも歩こう！　キャンサージャーニーを豊かにする
    運動のすすめ
    大島 和也、岩瀬 哲
    日経メディカル開発　2020/03/16　出版
  • Q&Aでわかる！病院・診療所の紛争予防・対応マニュアル
    長野佑紀,岩瀬　哲、他
    日本医事新報社　2021/09/10　出版

ページトップへ戻る